Back to Search
ANSH PUROHIT, M.D
M.D
Student in an Organized Health Care Education/Training Program
NPI: 1902591522Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Quinazoline derivatives as MC-I inhibitors: evaluation of myocardial uptake using Positron Emission Tomography in rat and non-human primate.
PMID 17604167·Bioorg Med Chem Lett·2007
7-preclinical
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
PMID 19614621·Allergy·2009
3-trial
Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates.
PMID 18716773·Eur J Nucl Med Mol Imaging·2009
7-preclinical
Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
PMID 18786604·Mol Cell Endocrinol·2009
7-preclinical
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.
PMID 19156141·Br J Cancer·2009
7-preclinical
The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.
PMID 18775469·Mol Cell Endocrinol·2009
8-other
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
PMID 19250195·Ann N Y Acad Sci·2009
6-review
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.
PMID 18972041·Org Biomol Chem·2008
8-other
Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
PMID 18590272·J Med Chem·2008
8-other
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
PMID 18816537·ChemMedChem·2008
8-other
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.
PMID 18841154·Br J Cancer·2008
7-preclinical
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
PMID 18927286·Clin Cancer Res·2008
7-preclinical
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
PMID 19000581·J Allergy Clin Immunol·2008
4-observational
2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.
PMID 18985042·Br J Cancer·2008
7-preclinical
Entomological studies for surveillance and prevention of dengue in arid and semi-arid districts of Rajasthan, India.
PMID 18592841·J Vector Borne Dis·2008
7-preclinical
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography.
PMID 18723489·Mol Cancer Ther·2008
7-preclinical
Variability of IgE reactivity profiles among European mite allergic patients.
PMID 19021722·Eur J Clin Invest·2008
7-preclinical
Recent developments of steroid sulfatase inhibitors as anti-cancer agents.
PMID 18855575·Anticancer Agents Med Chem·2008
6-review
Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy.
PMID 19112542·ScientificWorldJournal·2008
8-other
Proarrhythmic defects in Timothy syndrome require calmodulin kinase II.
PMID 19001023·Circulation·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4500 THIRTEENTH STREET
GULFPORT, MS 39501 - Phone
- (228) 822-6512
Quick Facts
- NPI
- 1902591522
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile